Enzana Enzalutamide 40 mg Capsules

Enzana Enzalutamide 40 mg Capsules are a prescription-only oncology formulation developed for use in regulated healthcare environments. The product contains enzalutamide, a well-established androgen receptor inhibitor used in advanced prostate cancer management under specialist supervision. AmeriDrugs supplies Enzana Enzalutamide 40 mg Capsules strictly for international markets, supporting licensed importers, hospitals, oncology centers, and institutional pharmacies in compliance with applicable regulatory requirements.

Active Ingredient

The active ingredient in this formulation is enzalutamide, a non-steroidal androgen receptor signaling inhibitor. Enzalutamide is designed to block multiple steps in the androgen receptor pathway, which plays a significant role in prostate cancer progression. This information is provided for regulatory and educational reference only.

Therapeutic Use (Informational)

Enzana Enzalutamide 40 mg Capsules are therapeutically associated with the treatment of certain forms of prostate cancer, as determined by qualified oncology professionals. This section is strictly informational and does not constitute medical advice, treatment recommendations, or patient guidance.

Dosage Form & Route

• Dosage Form: Capsules

• Route of Administration: Oral

Enzana Enzalutamide 40 mg Capsules are manufactured to ensure pharmaceutical consistency, stability, and suitability for hospital and institutional oncology use.

Quality & Manufacturing Standards

Enzana Enzalutamide 40 mg Capsules are manufactured under controlled pharmaceutical production systems aligned with internationally recognized quality standards. Each stage of production, from formulation to packaging, follows validated processes to ensure batch consistency, product integrity, and regulatory compliance for export-oriented oncology supply.

Packaging Information

• Pack configuration: 4 × 7 capsules (28 capsules per pack)

Packaging is designed to maintain product stability during storage and international transportation while meeting labeling and documentation requirements of regulated pharmaceutical markets.

Target Buyers

• Licensed pharmaceutical importers

• Oncology hospitals and cancer treatment centers

• Institutional and specialty pharmacies

• Authorized oncology drug distributors

Enzana Enzalutamide 40 mg Capsules are intended exclusively for professional healthcare procurement and are not promoted for direct consumer use.

Regulatory & Compliance Note

Enzana Enzalutamide 40 mg Capsules are classified as a prescription-only oncology medicine intended for hospital and institutional use only.
Supply is intended for licensed institutions and, where permitted by applicable regulations, may be available to retail customers strictly against a valid prescription.